Related Experiment Videos
Amniotic fluid embolism with second trimester pregnancy termination: a case report.
Barry K Ray1, Manuel C Vallejo, Mitchell D Creinin
1Department of Anesthesiology, Magee Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|February 10, 2004
Summary
Amniotic fluid embolism (AFE) is a rare but life-threatening condition during pregnancy termination. Prompt recognition and aggressive treatment, similar to anaphylaxis, are crucial for maternal survival.
Area of Science:
- Obstetrics and Gynecology
- Anesthesiology
- Critical Care Medicine
Background:
- Amniotic fluid embolism (AFE) is a rare obstetric emergency with high mortality.
- This case describes AFE during a second-trimester pregnancy termination, highlighting anesthetic challenges.
Observation:
- A 30-year-old woman experienced sudden hypotension, shock, and cardiac arrest during a dilatation and evacuation procedure.
- Intraoperative complications included hemorrhage and disseminated intravascular coagulopathy, suggesting AFE.
Findings:
- AFE pathophysiology resembles a type-1 hypersensitivity reaction, leading to cardiovascular collapse.
- Prompt diagnosis and management, including cardiopulmonary resuscitation and vasopressors, are vital.
Implications:
- AFE necessitates rapid intervention, mirroring anaphylaxis treatment protocols.
- Aggressive fluid resuscitation, blood products, and vasopressors are key in managing AFE during pregnancy termination.